Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-11), Koninklijke Philips NV's 3-1 Month Momentum % is 3.78%.
The industry rank for Koninklijke Philips NV's 3-1 Month Momentum % or its related term are showing as below:
XAMS:PHIA's 3-1 Month Momentum % is ranked better than 57.78% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 0.86
vs XAMS:PHIA: 3.78
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Koninklijke Philips NV 3-1 Month Momentum % Related Terms
XAMS:PHIA vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Koninklijke Philips NV's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koninklijke Philips NV (XAMS:PHIA) has a 3-1 Month Momentum % of 3.78% as of Sep. 11, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Koninklijke Philips NV and its competitors. According to the industry distribution chart, Koninklijke Philips NV ranks #358 out of 848 companies in the Medical Devices & Instruments industry, placing it in the top 42.2%.
Is Koninklijke Philips NV's 3-1 Month Momentum % too high?
Koninklijke Philips NV's current 3-1 Month Momentum % is 3.78%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.86. Koninklijke Philips NV's value of 3.78% is 339.5% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #358 out of 848 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #358 out of 848 companies for 3-1 Month Momentum %. This puts Koninklijke Philips NV in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.86. Koninklijke Philips NV's value of 3.78% is 339.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.86, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current 3-1 Month Momentum % of 3.78% is 339.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current 3-1 Month Momentum % is 3.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (XAMS:PHIA) is currently considered Fairly Valued. The stock's GF Value™ is €22.90, compared to a current price of €21.30 — trading 7% below its estimated fair value. The current 3-1 Month Momentum % is 3.78% and 339.5% above the Medical Devices & Instruments industry median of 0.86. Koninklijke Philips NV's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Koninklijke Philips NV (XAMS:PHIA), the current 3-1 Month Momentum % is 3.78% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (XAMS:PHIA) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be undervalued.
The current stock price of €21.30 is trading 7% below its estimated GF Value™ of €22.90.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for XAMS:PHIA:
3-1 Month Momentum %: 3.78%
GF Value™: €22.90 vs. price of €21.30 (7% below fair value)
Industry Position: 339.5% above the Medical Devices & Instruments median (#358 of 848)
No single metric tells the full story. See the XAMS:PHIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
71GF Score
Get the complete analysis for XAMS:PHIA
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAMS:PHIA has been successfully added to your 
